Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas AnalgesiaDermatologyMedical DeviceNeuroscienceOncology & HematologyPediatricsRare DiseaseOtherCOVID-19Cell & Gene TherapyWomen's HealthDiagnostics By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualitySafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting New FDA Draft Guidance Provides Insights on Use of PROs in Oncology Trials By Irene Figari July 7, 2021 Medical and Regulatory Affairs ANDA or 505(b)(2): Choosing the Right Abbreviated Approval Pathway for Your Drug By Kristi Miller June 29, 2021 Clinical ResearchPhase 1 - Phase 4 5 Key Takeaways: Drug and Device Development Secrets in the World of Medical Aesthetics By Jasmina Jankicevic May 27, 2021 Study Design Compensating for the Unknown: 3 Keys to Implementing a Successful Decentralized Clinical Trial By Nach Davé May 13, 2021 Global Compliance Frequently Asked Questions: GxP Quality Guidelines and Regulations By Premier Research May 12, 2021 Functional Service Provider (FSP) The Emerging Biotech’s Guide to Creating Scalable Infrastructure With a Functional Service Provider By Cheryl Silva April 27, 2021 Previous 1 2 3 4 5 … 43 Next × ALSO OF INTERESTNostalgia or Shell Shock? Assessing PTSD Is a...Designing Pediatric Analgesic Treatment...Gene Therapy 101: From the 1960s to Today
